Physician profile
Kevin Chow
NPI 1700316122
$9,457.55
in general payments reported to CMS, 2019-2025
19 companies · $2,172 in 2025
The $2,172 reported for 2025 was more than what 79% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2021: $187 · 2023: $5,334 · 2024: $1,504 · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,340 · Travel and Lodging: $3,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,340.22 |
| Travel and Lodging | $3,669.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,676.82 | 2023-2025 | Target, Trevo, Neuroform Atlas |
| Terumo Medical Corporation | $1,525.84 | 2023 | Glidesheath Slender, Navicross, Tr Band |
| Penumbra, INC. | $1,310.10 | 2023-2025 | Red 72, Penumbra System, Benchmark |
| Imperative Care, INC | $1,123.82 | 2023-2025 | Zoom 88-T Large Distal Platform |
| Medtronic, INC. | $945.49 | 2021-2025 | Pipeline, Solitaire X, Onyx 18 |
| Depuy Synthes Sales INC. | $532.48 | 2023-2025 | Embotrap, Cerebase, Trufill |
| Microvention, INC. | $299.79 | 2024-2025 | Tubing Kit - Stroke, Stent, Sofia 6f-131cm Str |
| Route 92 Medical, INC. | $254.26 | 2025 | |
| Globus Medical, INC. | $168.77 | 2025 | Excelsius Gps |
| Scientia Vascular | $154.98 | 2025 | Socrates 38 |
| Neurocrine Biosciences, INC. | $123.50 | 2019 | |
| Nuvasive, INC. | $111.56 | 2021 | |
| Acadia Pharmaceuticals INC | $73.74 | 2019 | |
| Chiesi USA, INC. | $51.85 | 2019 | |
| Allergan, INC. | $28.36 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Contego Medical, INC | $23.19 | 2025 | |
| Ossur Americas, INC. | $20.70 | 2025 | |
| Revance Therapeutics, INC. | $18.26 | 2024 | Daxxify |
| Abbott Laboratories | $14.04 | 2025 | Xact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.